Dipòsit Digital de Documents de la UAB 14 registres trobats  1 - 10següent  anar al registre: La cerca s'ha fet en 0.02 segons. 
1.
8 p, 799.5 KB Periaqueductal gray matter echogenicity as a marker of migraine chronification : a case control study / Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rubio, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gea, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ríos, José (Universitat Autònoma de Barcelona) ; Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernández-Pérez, María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Paré-Curell, Martí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Millán, Mònica (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Dorado Bouix, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Migraine is one of the most prevalent and disabling medical diseases in the world. The periaqueductal gray matter and the red nucleus play an important role in its pathogenesis. Our aim was to evaluate the echogenicity of the periaqueductal gray matter and the red nucleus in patients with migraine, by means of transcranial ultrasound. [...]
2023 - 10.1186/s10194-023-01576-3
Journal of headache and pain, Vol. 24 (april 2023)  
2.
13 p, 1.9 MB A study of differential microRNA expression profile in migraine : the microMIG exploratory study / Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gómez-Galván, J. B. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Asskour, L. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron) ; Caronna, Edoardo (Hospital Universitari Vall d'Hebron) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Several studies have described potential microRNA (miRNA) biomarkers associated with migraine, but studies are scarcely reproducible primarily due to the heterogeneous variability of participants. Increasing evidence shows that disease-related intrinsic factors together with lifestyle (environmental factors), influence epigenetic mechanisms and in turn, diseases. [...]
2023 - 10.1186/s10194-023-01542-z
Journal of headache and pain, Vol. 24 (february 2023)  
3.
10 p, 1.2 MB In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study / Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Patient-Reported Outcomes (PROs) have been developed to numerically quantify disability, impact and quality of life. They have been widely used in migraine clinical trials. However, we still do not know which PRO more accurately reflects preventive treatment response from a patient's perspective or which one may help us with treatment decisions in clinical practice. [...]
2021 - 10.1186/s10194-021-01366-9
Journal of headache and pain, Vol. 22 (december 2021)  
4.
8 p, 761.9 KB MAB-MIG : registry of the spanish neurological society of erenumab for migraine prevention / Belvís, Roberto (Institut d'Investigació Biomèdica Sant Pau) ; Irimia, Pablo (Clínica Universidad de Navarra) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; González-Oria, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Cano, Antonio (Hospital de Mataró. Consorci Sanitari del Maresme) ; Viguera, Javier (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Sánchez, Belén (Hospital Quirónsalud Zaragoza) ; Molina, Francisco (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Beltrán, Isabel (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Oterino, Agustín (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Cuadrado-Godia, Elisa (Hospital del Mar (Barcelona, Catalunya)) ; Gómez-Camello, Angel (Hospital Universitario San Cecilio (Granada)) ; Alberte-Woodward, Miguel (Hospital Universitario Lucus Augusti (Lugo)) ; Jurado, Carmen (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Oms, Teresa (Hospital Dos de Maig) ; Ezpeleta, David (Hospital Quironsalud Madrid) ; de Terán, Javier Díaz (Hospital Universitario La Paz (Madrid)) ; Morollón Sánchez-Mateos, Noemí (Hospital Universitari Dexeus (Barcelona, Catalunya)) ; Latorre, Germán (Hospital Universitario de Fuenlabrada ( Madrid)) ; Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lamas, Raquel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Toledano, Carlos (Clínica Universidad de Navarra) ; Leira, Rogelio (Complejo Hospitalario Universitario de Santiago de Compostela) ; Santos, Sonia (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Del Rio, Margarita Sanchez (Clínica Universidad de Navarra) ; Universitat Autònoma de Barcelona
Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized managed access program, which allowed free access to erenumab before official reimbursement. [...]
2021 - 10.1186/s10194-021-01267-x
Journal of headache and pain, Vol. 22 (july 2021)  
5.
11 p, 1005.5 KB Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18 FDG-PET and MRI study / Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cuberas-Borrós, Gemma (Hospital Universitari Vall d'Hebron) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vila-Balló, Adrià (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lorenzo-Bosquet, Carles (Hospital Universitari Vall d'Hebron) ; Castell-Conesa, Joan (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
To describe interictal brain structural and metabolic differences between patients with episodic migraine (EM), chronic migraine (CM) and healthy controls (HC). This is an exploratory study including right-handed age-matched women with EM, CM and HC. [...]
2021 - 10.1186/s10194-021-01289-5
Journal of headache and pain, Vol. 22 (july 2021)  
6.
10 p, 1.9 MB InterMiG : international differences in the therapeutic approach to migraine patients in specialized headache centers / Gago-Veiga, Ana Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ; Huhn, J-I (Praxis Gendolla) ; Latysheva, Nina (I.M.Sechenov First Moscow State Medical University) ; Vieira Campos, A. (Instituto de Investigación Hospital Universitario de la Princesa) ; Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sacco, Simona (University of L'Aquila) ; Frattale, Ilaria (University of L'Aquila) ; Ornello, R. (University of L'Aquila) ; Ruscheweyh, Ruth (Ludwig Maximilians University Munich) ; Marques, I. B. (Hospital da Luz (Lisboa, Portugal)) ; Gryglas-Dworak, A. (Private Headache Clinic (Polònia)) ; Stark, C. (Austin Health) ; Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
There is currently a wide therapeutic arsenal for migraine patients, without a single first-line preventive drug and we choose the different available alternatives taking into account comorbidities, national guidelines, previous treatments and personal experiences. [...]
2021 - 10.1186/s10194-021-01258-y
Journal of headache and pain, Vol. 22 (may 2021)  
7.
12 p, 2.1 MB European headache federation consensus on the definition of resistant and refractory migraine / Sacco, Simona (Regional Referral Headache Center of the Abruzzo region) ; Braschinsky, Mark (Tartu University Clinics) ; Ducros, Anne (University Hospital of Montpellier (França)) ; Lampl, Christian (Hospital Barmherzige Brüder) ; Little, Patrick (European Migraine & Hendrik Ido Ambacht) ; van den Brink, Antoinette Maassen (Erasmus MC University Medical Center Rotterdam) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reuter, Uwe (Charité - Universitätsmedizin Berlin) ; de la Torre, Elena Ruiz (Hendrik Ido Ambacht) ; Del Rio, Margarita Sanchez (Clínica Universidad de Navarra) ; Sinclair, Alexandra J. (Birmingham Health Partners) ; Katsarava, Zaza (IM Sechenov First Moscow State Medical University) ; Martelletti, Paolo (Sant'Andrea Hospital) ; Universitat Autònoma de Barcelona
Despite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief with acute and preventive treatments. It is the aim of the present document to provide a definition of those migraines which are difficult-to-treat, to create awareness of existence of this group of patients, to help Healthcare Authorities in understanding the implications, and to create a basis to develop a better pathophysiological understanding and to support further therapeutic advances. [...]
2020 - 10.1186/s10194-020-01130-5
Journal of headache and pain, Vol. 21 (june 2020)  
8.
8 p, 365.5 KB Low-value care practice in headache : a Spanish mixed methods research study / Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Layos-Romero, Almudena (Complejo Hospitalario Universitario de Albacete) ; Martin-Delgado, Jimmy (ATENEA research group (Alacant)) ; Pascual Gómez, Julio (Universidad de Cantabria) ; Bailón-Santamaría, Cristina (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Tentor, Ana (Barrio del Pilar Health Center (Madrid)) ; Santiago, Alejandro (Hospital Universitario Infanta Leonor) ; Ignacio, Emilio (Cádiz University) ; Torrés, Antonio (Patient Safety Observatory, Andalusian Healthcare Quality Agency, Seville, Spain) ; Mira, José Joaquín (Universitat Miguel Hernández) ; Universitat Autònoma de Barcelona
Headache is one of the most prevalent diseases. The Global Burden of Disease Study ranks it as the seventh most common disease overall and the second largest neurological cause of disability in the world. [...]
2020 - 10.1186/s10194-020-01147-w
Journal of headache and pain, Vol. 21 (june 2020)  
9.
10 p, 2.3 MB Burden and attitude to resistant and refractory migraine : a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance / Sacco, Simona (ASL Avezzano-Sulmona-L'Aquila) ; Lampl, Christian (Hospital Barmherzige Brüder) ; Maassen van den Brink, Antoinette (Erasmus MC University Medical Center Rotterdam) ; Caponnetto, Valeria (ASL Avezzano-Sulmona-L'Aquila) ; Ducros, Anne (University Hospital of Montpellier (França)) ; Little, Patrick (European Migraine & Headache Alliance (EMHA), Brussels) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reuter, Uwe (Charité - Universitätsmedizin Berlin) ; Ruiz de la Torre, Elena (European Migraine & Headache Alliance (EMHA), Brussels) ; Sánchez Del Rio, Margarita (Clínica Universidad de Navarra) ; Sinclair, Alexandra J. (Birmingham Health Partners) ; Martelletti, Paolo (Sant'Andrea Hospital) ; Katsarava, Zaza (IM Sechenov First Moscow State Medical University) ; Universitat Autònoma de Barcelona
New treatments are currently offering new opportunities and challenges in clinical management and research in the migraine field. There is the need of homogenous criteria to identify candidates for treatment escalation as well as of reliable criteria to identify refractoriness to treatment. [...]
2021 - 10.1186/s10194-021-01252-4
Journal of headache and pain, Vol. 22 (may 2021)  
10.
10 p, 964.3 KB Guideline on the use of onabotulinumtoxinA in chronic migraine : a consensus statement from the European Headache Federation / Bendtsen, Lars (University of Copenhagen) ; Sacco, Simona (University of L'Aquila. Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology) ; Ashina, Messoud (University of Copenhagen) ; Mitsikostas, Dimos (National and Kapodistrian University of Athens. 1st Department of Neurology, Aeginition Hospital) ; Ahmed, Fayyaz (Hull York Medical School. Department of Neurosciences) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martelletti, Paolo (Sapienza University. Department of Clinical and Molecular Medicine) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. [...]
2018 - 10.1186/s10194-018-0921-8
Journal of headache and pain, Vol. 19 (september 2018)  

Dipòsit Digital de Documents de la UAB : 14 registres trobats   1 - 10següent  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.